Japanese Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Apellis Pharmaceuticals: Eye Disease Drug On Comeback Trail - Risks Remain (NASDAQ:APLS)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Arcturus: COVID Vaccine Approval Shots In Japan And Europe Key To Unlocking Upside (NASDAQ:ARCT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
ImmunoGen Stock: Takeda Swoops For Slice Of Elahere (NASDAQ:IMGN)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Japanâs health names latch onto Vietnam 14:00 | 05/02/2021
Vietnamâs healthcare expenditures reached around $17 billion in 2019, photo Le Toan
The second-largest pharmaceutical company in Japan, Daiichi Sankyo Co., Ltd., has entered a licence agreement with Mitsubishi Tanabe Pharma Corporation to register and launch edaravone brand Radicava in Vietnam. The medication treats patients with amyotrophic lateral sclerosis and helps with recovery from a stroke.
Yukinori Tominaga, general director of Daiichi Sankyo Vietnam Co., Ltd., told VIR, âWe are going to provide more access to new medications in order to increase options for Vietnamese doctors to improve the quality of life in Vietnamese people.â